Vycor Medical Inc.

58 articles about Vycor Medical Inc.

• Vycor Medical, Inc. Agrees New NovaVision Licensing Agreement

  6/30/2020

  Vycor Medical, Inc. announced that its wholly owned subsidiary, NovaVision, Inc., has signed an agreement in principle to enter into an exclusive licensing agreement with HelferApp GmbH.

• Vycor Medical Reports Financial Results for the year ended December 31st, 2019

  3/27/2020

  Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2019. Highlights The Vycor Medical division recorded revenue of $1,300,000 from the sale of its products for the year ended December 31, 2019, a decrease of $11,000 (or 1%) over 2018. The US continued to experience growth (increase of 28%), primarily as a result o

• Treatment for blindness successful in largest ever study

  2/26/2020

  A new treatment has been found to be successful in improving the vision of partially blind patients.

• Vycor Announces That it is Accelerating the Roll-out of its Enhanced VBAS due to Surgeon Feedback

  3/6/2018

  Following surgeon feedback Vycor has decided that it will from now be shipping only the enhanced model VBAS across the complete main range of 12 VBAS sizes.

• Vycor Medical Inc. Release: New Clinical Study On NeuroEyeCoach Conclusively Supports Meaningful Improvement In Eye Movement Efficiency

  9/28/2016

• Vycor Medical Inc. Launches VBASMini

  3/16/2016

• Vycor Medical Inc.'s NovaVision Launches Its European Internet-Delivered Therapy Suite At The 3rd European Conference Of Neurorehabilitation

  11/30/2015

• New Clinical Data Released At The World Congress Of Neuroendoscopy Conclusively Points To Vycor Medical Inc.'s VBAS Reducing Post Operative Patient Length Of Stay In Hospital

  11/18/2015

• New Clinical Data In Japan Demonstrates Benefits Of Using Vycor Medical Inc.'s VBAS With Karl Storz's VITOM Exoscope For Surgery Of Deep-Seated Tumors

  10/28/2015

• Vycor Medical Inc. To Unveil VBAS Product Line Extension And Prototypes At CNS 65th Annual Meeting In New Orleans, September 26-30, 2015

  9/28/2015

• Vycor Medical Inc. To Present At The 4th Annual Liolios Gateway Conference On September 10, 2015

  9/1/2015

• World Neurosurgery Publishes New Clinical Study Performed At The Walter Reed Army Institute of Research Medical Center Showing Positive Performance Of Vycor Medical Inc.'s VBAS In The Treatment Of Wartime Brain Injuries

  8/12/2015

• Vycor Medical Inc. Announces Commercial Release of Its NovaVision Web Deliverable Therapy Suite

  6/25/2015

• Vycor Medical Inc. Signs Agreement With HEALTHSOUTH For Second NovaVision Therapy Product

  6/8/2015

• Vycor Medical Inc. Continues To Execute On Its Stated Strategic Goal Of Expanding Internationally

  10/14/2014

• Prominent Researchers to Present Minimally Invasive Surgeries Utilizing Vycor Medical Inc.'s VBAS At Congress Of Neurosurgery

  10/10/2014

• Vycor Medical Inc. Reports 41% Year-to-Date Revenue Growth

  8/12/2014

• Vycor Medical Inc. Release: New Image Guided VBAS Prototype Work Completed

  8/8/2014

• Vycor Medical Inc. Boosts Shareholder Equity By $2.4 Million

  8/6/2014

• Vycor Medical Inc. To Present At The LD Micro 4th Invitational Conference

  5/30/2014